Analysis of the immunological response to coronavirus infection
COVID-19 is an illness caused by the coronavirus, SARS-CoV-2. It affects people in very different ways, from no symptoms at all to severe lung infections. This study, led by the University of Birmingham, aims to understand how different immune systems respond to the virus. Researchers are collecting blood samples, nose swabs, and saliva from people with active infections, people who have recovered, and healthy volunteers who have not had the virus. By comparing these groups, scientists hope to learn why some people get much sicker than others and how our bodies build natural protection. Taking part is straightforward and involves donating standard samples. While participants will not receive direct personal health benefits, their contribution helps scientists gather crucial knowledge to fight coronavirus now and in the future. The trial is scheduled to run until June 2025.
At a glance
What is this study about?
COVID-19 is a respiratory illness caused by the coronavirus, SARS-CoV-2. Since it first appeared in 2019, it has affected millions of people across the globe. While some people catch the virus and feel completely fine, others develop a cough, fever, or even severe lung infections like pneumonia. Because people react so differently, scientists want to look closely at our immune systems—the body's natural defence network—to see how they handle the virus.
This study, run by the University of Birmingham, is examining the body's immune response in detail. Researchers are taking samples from people who currently have COVID-19, people who have had it in the past and recovered, and people who have never been infected. By comparing these different groups, the research team hopes to uncover why some immune systems fight off the illness easily while others struggle.
Understanding these immune patterns is vital. The findings could help doctors predict who is most at risk of severe illness and guide the design of better treatments and protective vaccines for the future. The study is funded by the Medical Research Council and the UK Department of Health and Social Care, running until June 2025.
Key takeaways
- The study explores how human immune systems respond to the virus that causes COVID-19.
- Participation involves donating blood samples, nose swabs, or saliva.
- People of all ages, both with and without previous infection, are being studied.
- No new medicines or experimental treatments are tested in this trial.
- The study is run by the University of Birmingham and runs until June 2025.
- Researchers are identifying participants directly in hospitals rather than through public sign-ups.
Who may be eligible?
This study is open to people of any age and gender. The researchers need both people who have tested positive for the coronavirus (whether they felt ill or had no symptoms at all) and people who have tested negative to act as a comparison group.
To ensure fair results, researchers match healthy volunteers with patients based on similar traits like age. Anyone who has had a test for SARS-CoV-2 may be considered, provided they meet the specific needs of the current part of the project.
Please note that the study is not currently looking for public sign-ups. The research team is directly approaching patients and volunteers through selected hospitals and local clinics.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- You have been tested for the SARS-CoV-2 coronavirus (positive or negative).
- You are being treated at or attending a participating hospital or clinic.
- You are willing to donate a blood sample, nose swab, or saliva sample.
- You have been directly invited by the hospital research team to join.
What does participation involve?
If you are invited to join the study, you will be asked to donate samples such as a small amount of blood, a nose swab, or saliva. In many cases, these samples can be collected at the same time as your routine hospital or clinic appointments, so you may not need an extra visit.
There are no new medicines, experimental drugs, or treatments to take as part of this research. The exact number of samples and how often you give them will depend on the specific part of the study you join. The overall project runs until June 2025, but your personal time commitment could simply be a one-off donation or a few short check-ins.
Potential risks and benefits
Locations (3)
- Queen Elizabeth Hospital BirminghamApproximateBirmingham, England
- Heartlands Hospital Bordesley Green EastApproximateBirmingham, England
- Good Hope HospitalApproximateSutton Coldfield, England
Common questions
Can I sign up for this trial online?
No. The research team is directly inviting patients from specific hospitals and clinics, so open public registration is not available at this time.
Will I have to take any new medicines?
No. This study only collects samples like blood, saliva, or swabs. It does not test any new drugs or treatments.
Do I need to have had COVID-19 to take part?
Not necessarily. The study also needs healthy volunteers who have tested negative to compare against those who had the infection.
Does giving a blood sample hurt?
You may feel a slight prick when the needle goes in. Some people get a small bruise or slight ache afterwards, but this usually clears up quickly.
Can I change my mind after agreeing to join?
Yes. You can leave the study at any point. Your decision will have no impact on the regular medical care you receive.
How to find out more
Paul Moss
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.